MedTrace Logo

Prospective Evaluation of Patients With Uterine Cervical Cancer in Brazilian Health Institutions - The EVITA I Study

NCT02671071 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 638

Last updated 2021-12-27

No results posted yet for this study

Summary

The primary objective of this study is to describe the socio-demographic, clinical pathological, quality of life and treatment characteristics of patients diagnosed with CC in Brazil.

Conditions

  • Cervix Cancer

Interventions

BEHAVIORAL

Quality of Life Questionnaire (QLQ)

The European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire-Cervical cancer module (EORTC QLQ-CX24) will be applied to all patients at 0, 3, 6, 12, 24, 36 months.

Sponsors & Collaborators

  • EVA - Grupo Brasileiro de Tumores Ginecológicos

    collaborator UNKNOWN

  • Roche Pharma AG

    collaborator INDUSTRY

  • Latin American Cooperative Oncology Group

    lead OTHER

Principal Investigators

  • Gustavo Werutsky, MD · Latin American Cooperative Oncology Group

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2020-12-31
Completion
2021-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02671071 on ClinicalTrials.gov